PROBENECID - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for probenecid and what is the scope of patent protection?
Probenecid
is the generic ingredient in three branded drugs marketed by Merck, Lannett, Aurobindo Pharma Usa, Ivax Sub Teva Pharms, Lederle, Rising, Watson Labs, and Watson Labs Teva, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for probenecid. Six suppliers are listed for this compound.
Summary for PROBENECID
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Master File Entries: | 10 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 70 |
| Patent Applications: | 6,848 |
| Drug Prices: | Drug price trends for PROBENECID |
| What excipients (inactive ingredients) are in PROBENECID? | PROBENECID excipients list |
| DailyMed Link: | PROBENECID at DailyMed |
Recent Clinical Trials for PROBENECID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| TrippBio, Inc. | Phase 1 |
| Guangdong Raynovent Biotech Co., Ltd | Phase 1 |
| United States Department of Defense | Phase 3 |
Medical Subject Heading (MeSH) Categories for PROBENECID
Anatomical Therapeutic Chemical (ATC) Classes for PROBENECID
US Patents and Regulatory Information for PROBENECID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Sub Teva Pharms | PROBENECID | probenecid | TABLET;ORAL | 083740-001 | May 9, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | PROBENECID | probenecid | TABLET;ORAL | 217020-001 | Nov 20, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lannett | PROBALAN | probenecid | TABLET;ORAL | 080966-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Usa | PROBENECID | probenecid | TABLET;ORAL | 084211-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | BENEMID | probenecid | TABLET;ORAL | 007898-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PROBENECID | probenecid | TABLET;ORAL | 086150-002 | Apr 23, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
